Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Stem Cell Transplantation for Hurler
This study is ongoing, but not recruiting participants.
Study NCT00176917 Information provided by Masonic Cancer Center, University of Minnesota
First Received: September 12, 2005 Last Updated: July 28, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mucopolysaccharidosis I
Mucopolysaccharidosis VI
Mannosidosis
Additional conditions recognized in this trial
Alpha-Mannosidosis
Mannosidase Deficiency Diseases
Mucolipidoses
Mucopolysaccharidoses
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Carbohydrate Metabolism, Inborn Errors
Central Nervous System Diseases
Connective Tissue Diseases
Genetic Diseases, Inborn
Lysosomal Storage Diseases
Lysosomal Storage Diseases, Nervous System
Metabolic Diseases
Metabolism, Inborn Errors
Mucinoses
Musculoskeletal Diseases
Nervous System Diseases
Interventions listed in this trial
Stem Cell Transplant
Busulfan, Cyclophosphamide, ATG
Additional drug interventions recognized in this trial
Busulfan
Cyclophosphamide
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Masonic Cancer Center, University of Minnesota
Back to top of Main Content
